[HTML][HTML] Alzheimer's disease: A mini-review for the clinician

RS Madnani - Frontiers in Neurology, 2023 - frontiersin.org
Alzheimer's disease (AD), the most common form of dementia, is a striking example of the
connection between neurophysiological abnormalities and higher-order cognitive …

Alzheimer disease

DS Knopman, H Amieva, RC Petersen… - Nature reviews Disease …, 2021 - nature.com
Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing
plaques and tau-containing neurofibrillary tangles. AD is a genetic and sporadic …

Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis

S Mondragón-Rodríguez, G Basurto-Islas… - Expert Review of …, 2010 - Taylor & Francis
Amyloid plaques and neurofibrillary tangles are the hallmarks of Alzheimer's disease and
have been the focus of disease etiology and pathogenesis. However, in the larger picture of …

Is Alzheimer disease a disease?

AD Korczyn, LT Grinberg - Nature Reviews Neurology, 2024 - nature.com
Dementia, a prevalent condition among older individuals, has profound societal
implications. Extensive research has resulted in no cure for what is perceived as the most …

[引用][C] The special topics section of Alzheimer's & dementia

ZS Khachaturian, MM Mesulam… - Alzheimer's & …, 2015 - Wiley Online Library
The editors of Alzheimer's & Dementia announce the launch of a new Journal feature called
the “Special Topics Section”. The first special topic section will review and assess the current …

Multifaceted Alzheimer's disease: Building a roadmap for advancement of novel therapies

D Kaur, T Behl, A Sehgal, S Singh, N Sharma… - Neurochemical …, 2021 - Springer
Alzheimer's disease (AD) is one of the most prevailing neurodegenerative disorders of
elderly humans associated with cognitive damage. Biochemical, epigenetic, and …

The future of Alzheimer's disease: the next 10 years

H Hampel, D Prvulovic, S Teipel, F Jessen… - Progress in …, 2011 - Elsevier
Alzheimer's disease (AD) is a fast growing world-wide epidemic. AD is a genetically
complex, slowly progressive, and irreversible neurodegenerative disease of the brain …

[HTML][HTML] Alzheimer's disease–the journey of a healthy brain into organ failure

TE Golde - Molecular Neurodegeneration, 2022 - Springer
As the most common dementia, Alzheimer's disease (AD) exacts an immense personal,
societal, and economic toll. AD was first described at the neuropathological level in the early …

Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream

A Nunomura, RJ Castellani, H Lee, PI Moreira… - Science of Aging …, 2006 - science.org
For one hundred years after Alois Alzheimer's first report of Alzheimer's disease (AD) in
1906, the pathological hallmarks of the disease, senile plaques and neurofibrillary tangles …

[HTML][HTML] Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease

I Mumtaz, MO Ayaz, MS Khan, U Manzoor… - Frontiers in Aging …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disorder that causes progressive loss of
cognitive functions like thinking, memory, reasoning, behavioral abilities, and social skills …